This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract, valued at $10,929.26, is for the delivery of Telmisartan-HCTZ 80-25 mg tablets. The contract has a firm fixed-price pricing type and an ultimate completion date of January 2, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA...
This is a $1,935.05 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract provides for the supply of 4564598993 - TELMISARTAN-HCTZ 80-25 MG TAB UD 30S, with an ultimate completion date of May 15, 2024. This delivery order is placed under Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of TELMISARTAN-HCTZ 40-12.5 MG TB UD 30S, a cardiovascular medication. The award has a ceiling value of $5,963.04 and a period of performance through February 7, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen...
This is a Delivery Order contract award by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of TELMISARTAN-HCTZ 80-25 MG TAB 30S. The award has a ceiling value of $2,421.09 and a period of performance through July 19, 2024. The contract is a Firm Fixed Price arrangement. This award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TELMISARTAN-HCTZ 80-25 MG TAB 30S, a cardiovascular medication, with a ceiling value of $2,179.14 and a performance period through May 28, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of TELMISARTAN-HCTZ 80-25 MG TAB UD 30S, a cardiovascular medication, with a ceiling value of $4,917.96 and a performance period through March 20, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $79,696.86, is for the delivery of TELMISARTAN-HCTZ 40-12.5 MG TB UD 30S, a cardiovascular medication. The contract has a period of performance through July 10, 2024 and is a firm fixed-price contract type. This contract is associated with a larger Indefinite Delivery Contract (IDC) that...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,806.50, is for the delivery of TELMISARTAN-HCTZ 80-25 MG TAB UD 30S, which are pharmaceutical tablets. The contract is a firm fixed price delivery order with an ultimate completion date of April 9, 2025. The contract was awarded on April 8, 2025 and does not have a set-aside designation,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,749.34 firm fixed-price contract is for the supply of 4563061798 TELMISARTAN-HCTZ 40-12.5 MG TB UD 30S, a cardiovascular medication. The contract has an ultimate completion date of December 12, 2023 and was awarded on December 11, 2023. This order is placed against AmerisourceBergen's...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,775.61, is a delivery order for the supply of 4566659455 TELMISARTAN-HCTZ 40-12.5 MG TB UD 30S, a cardiovascular medication. The contract has a firm fixed price pricing type and an ultimate completion date of December 10, 2024. The award is not designated as a set-aside contract. This contract...